Intertek Pharmaceutical Services at ICSE 2010
The Intertek Team will be launching some important new and expanded services at ICSE 2010. New services include GMP Microbiology Services and expanded capabilities for Extractable / Leachable studies.
ICSE Booth: 4BIO34
pharma-europe@intertek.com
The Intertek Team will be launching some important new and expanded services at ICSE 2010. New services include GMP Microbiology Services and expanded capabilities for Extractable / Leachable studies.
Breaking news at the Intertek centre of excellence for biopharmaceutical characterization in Manchester brings a significant increase in LC-MS/MS characterization capabilities for protein and antibody therapeutics contributing to our existing protein characterization suite catering for all requirements of the ICHQ6B Guidelines. Capabilities include peptide mapping, amino acid analysis, amino acid sequencing, PTM and glycosylation analysis and more. Intertek are happy to announce a FREE SEMINAR on the 23rd of Nov in Manchester focusing on the requirements of ICH Q6B and the analytics to achieve compliance. Please contact us to request further information or drop by the ICSE stand to find out more.
Come meet the team to find out about our latest facility expansion which has seen our GMP facility in Athlone Ireland significantly increase its laboratory footprint and find out about our new GLP facility in Basel, Switzerland. Our team is ready to answer any questions you may have about or GLP bioanalytical, GMP pharmaceutical analysis and GMP microbiology capabilities. We look forward to meeting you in Paris!
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
